Schizophrenia Related Peptide (Highly Pure)

<strong>Schizophrenia Related Peptide</strong>_x000D_ <strong>Catalog number:</strong> B2012653_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 500 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Lyophilized Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Synthetic Peptides_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Upthegrove R, Khandaker GM. Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia Curr Top Behav Neurosci. 2020;44:49-66._x000D_ 2: Na KS, Jung HY, Kim YK. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:277-86._x000D_ 3: Di Carlo P, Punzi G, Ursini G. Brain-derived neurotrophic factor and schizophrenia Psychiatr Genet. 2019 Oct;29(5):200-210._x000D_ 4: López A, Mendieta L, Prades R, Royo S, Tarragó T, Giralt E. Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia Future Med Chem. 2013 Sep;5(13):1509-23._x000D_ 5: Xuan FL, Yan L, Li Y, Fan F, Deng H, Gou M, Chithanathan K, Heinla I, Yuan L, Seppa K, Zharkovsky A, Kalda A, Hong LE, Hu GF, Tan Y, Tian L. Glial receptor PLXNB2 regulates schizophrenia-related stress perception via the amygdala Front Immunol. 2022 Oct 17;13:1005067._x000D_ 6: Talaei A, Farkhondeh T, Forouzanfar F. Fibroblast Growth Factor: Promising Target for Schizophrenia Curr Drug Targets. 2020;21(13):1344-1353._x000D_ 7: LaCrosse AL, Olive MF. Neuropeptide systems and schizophrenia CNS Neurol Disord Drug Targets. 2013 Aug;12(5):619-32._x000D_ 8: Berry T, Abohamza E, Moustafa AA. Treatment-resistant schizophrenia: focus on the transsulfuration pathway Rev Neurosci. 2020 Jan 28;31(2):219-232._x000D_ 9: Mizui T, Hattori K, Ishiwata S, Hidese S, Yoshida S, Kunugi H, Kojima M. Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia J Psychiatr Res. 2019 Jun;113:190-198._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/28049076">10: Urban-Kowalczyk M, Śmigielski J, Strzelecki D. Olfactory identification in patients with schizophrenia - the influence of β-endorphin and calcitonin gene-related peptide concentrations Eur Psychiatry. 2017 Mar;41:16-20. </a>_x000D_ _x000D_ <strong>Products Related to Schizophrenia Related Peptide can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>